Insights

Articles and use cases on pharmaceutical and medical knowledge management — ontologies, semantic search, AI-ready data, and regulatory intelligence.

DNA double helix representing molecular target identification Drug Discovery

Ontology-Driven Target Identification in Early Drug Discovery

Target identification — the process of selecting the molecular target most likely to yield a safe and effective drug for a specific disease — is one of the highest-stakes decisions in pharmaceutical development. Knowledge graphs that integrate genetics, proteomics, disease biology, and clinical evidence provide a structured framework for making this decision with less uncertainty.

2 Feb 2026 · 9 min read
Pharmaceutical compounds representing drug repurposing opportunities Drug Discovery

Drug Repurposing Using Indication Knowledge Graphs

Drug repurposing — identifying new therapeutic uses for existing compounds — is the most efficient path to clinical proof of concept because the safety profile is already established. Indication knowledge graphs enable systematic, data-driven repurposing hypothesis generation at a scale that cannot be achieved through literature review alone.

9 Feb 2026 · 8 min read
Microscope and laboratory representing multi-omics research Drug Discovery

Semantic Integration of Genomics, Proteomics, and Clinical Data

The integration of genomics, proteomics, transcriptomics, and clinical data into a unified analytical framework is the technical foundation of precision medicine drug discovery. Without a semantic layer that defines how concepts from each data modality relate to each other, multi-omics integration produces noise rather than insight.

16 Feb 2026 · 9 min read
Chemistry laboratory representing biomarker research and validation Drug Discovery

Knowledge Graphs for Biomarker Discovery

Biomarker discovery — identifying molecular features that predict disease risk, progression, or treatment response — is one of the most knowledge-intensive activities in pharmaceutical research. Knowledge graphs that formalise the relationships between molecular entities, disease biology, and clinical outcomes dramatically accelerate hypothesis generation.

23 Feb 2026 · 8 min read
Research laboratory connecting preclinical and clinical data Drug Discovery

Unifying Preclinical and Clinical Knowledge Through Ontologies

The translation gap between preclinical and clinical drug development — where efficacy signals in animal models fail to predict human efficacy — is partly a knowledge gap. Ontologies that formally align preclinical biological concepts with their clinical counterparts reduce this gap by making translational comparisons systematic rather than ad hoc.

2 Mar 2026 · 8 min read